MAVERIC: Midlands trial of amiodarone vs electrophysiology-guided interventions and cardio-defibrillator in ventricular arrhythmias.

ISRCTN ISRCTN14274472
DOI https://doi.org/10.1186/ISRCTN14274472
Secondary identifying numbers ID6
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
21/12/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Michael Griffith
Scientific

Department of Cardiology
Queen Elizabeth Hospital
Edgbaston
Birmingham
B15 2TH
United Kingdom

Phone +44 (0)121 627 2043

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study acronymMAVERIC
Study objectivesThe optimal way to manage patients who present with sustained ventricular tachycardia (VT), ventricular fibrillation (VF) or sudden cardiac death (SCD), especially in the context of comparing the traditional approach of empirical amiodarone against electrophysiology-guided interventions, which include myocardial revsacularisation, programmed ventricular stimulation and the implantable cardioverter-defibrillator (ICD).
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCardiovascular diseases: Heart disease
InterventionElectrophysiology + implantable cardioverter defibrillators (ICDs) versus Amiodarone empirically
Intervention typeOther
Primary outcome measure1. Death
2. Arrhythmia recurrence
3. Hospitalisation
4. Drug use
5. Quality of life
6. Cost of managing patients
Secondary outcome measuresNot provided at time of registration
Overall study start date01/11/1996
Completion date30/11/1999

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants214 (Added 19/11/09)
Key inclusion criteria1. Patients who presented with sustained ventricular tachycardia (VT), ventricular fibrillation (VF) or sudden cardiac death (SCD) and survived to reach hospital within the Midlands from Feb 1997 to Jan 1999 were actively identified and entered into the study.
2. Patients who were not of child-bearing age or had a life-expectancy of <6 months from a non-arrhythmic cause were approached for entry into the trial.

Patients who were ineligible for or refused to join the trial were entered into the study's registry.
Key exclusion criteriaDoes not match inclusion criteria
Date of first enrolment01/11/1996
Date of final enrolment30/11/1999

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Department of Cardiology
Birmingham
B15 2TH
United Kingdom

Sponsor information

Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.doh.gov.uk

Funders

Funder type

Government

NHS Cardiovascular Disease and Stroke National Research and Development Programme (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 01/07/1998 Yes No
Results article results 01/07/2004 Yes No